Financhill
Sell
25

IMRX Quote, Financials, Valuation and Earnings

Last price:
$6.40
Seasonality move :
-21.18%
Day range:
$6.35 - $6.71
52-week range:
$1.10 - $10.08
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
323.21x
P/B ratio:
1.81x
Volume:
742.5K
Avg. volume:
1.1M
1-year change:
199.07%
Market cap:
$413.2M
Revenue:
--
EPS (TTM):
-$1.78

Earnings Data

Next earnings date for IMRX
Mar 19
2026
Most recent earnings per share
-$0.38
Beat by $0.01
(Nov 12/2025)
Consensus Estimate
-$0.39
(Nov 12/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

IMRX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/19/2026 Q4 -- -- -- -$0.31 --
11/12/2025 Q3 -- -- -$0.38 -$0.39 $0.01
08/13/2025 Q2 -- -- -$0.40 -$0.40 -$0.00
05/06/2025 Q1 -- -- -$0.42 -$0.59 $0.16
03/20/2025 Q4 -- -- -$0.58 -$0.45 -$0.14
11/13/2024 Q3 -- -- -$0.49 -$0.55 $0.06
08/06/2024 Q2 -- -- -$0.47 -$0.53 $0.05
05/07/2024 Q1 -- -- -$0.49 -$0.50 $0.02
03/01/2024 Q4 -- -- -$0.52 -$0.48 -$0.04
11/09/2023 Q3 -- -- -$0.43 -$0.49 $0.06
08/03/2023 Q2 -- -- -$0.43 -- --
05/04/2023 Q1 -- -- -$0.51 -- --
03/06/2023 Q4 -- $500 -$0.50 -- --
11/10/2022 Q3 -- $38.4K -$0.49 -- --
08/10/2022 Q2 -- $94.4K -$0.44 -- --
05/10/2022 Q1 -- $183.7K -$0.49 -- --
03/10/2022 Q4 -- $189.6K -$0.41 -- --
11/09/2021 Q3 -- $482.1K -$0.33 -- --
09/09/2021 Q2 -- $660K -$0.31 -- --
03/31/2021 Q1 -- $748.2K -$0.24 -- --
12/31/2020 Q4 -- $665.1K -$0.43 -- --
09/30/2020 Q3 -- $682.6K -$0.17 -- --
06/30/2020 Q2 -- $480.8K -$0.14 -- --
03/31/2020 Q1 -- $483K -$0.13 -- --

Immuneering Corp. Earnings Questions

  • How Much did Immuneering Corp. Generate in Revenue Last Quarter?

    Immuneering Corp. reported -- worth of top line sales in its most recent quarter.

  • Did Immuneering Corp. Beat Earnings Last Quarter?

    Immuneering Corp. announced earnings per share of -$0.38 which represents a beat of analyst forecast a -$0.39 per share.

  • Is Immuneering Corp. Profitable?

    Immuneering Corp. reported -$86.2K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for Immuneering Corp. EPS Next Year?

    Immuneering Corp.'s earnings are forecast to decrease from -$2.04 per share to -$1.82 per share next year representing a decrease of -30.41%.

  • When is Immuneering Corp.'s Earnings Date?

    Immuneering Corp.'s next earnings date is March 19, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
81
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Buy
56
SMX alert for Dec 6

SMX (Security Matters) Plc [SMX] is up 134.09% over the past day.

Buy
62
PRAX alert for Dec 6

Praxis Precision Medicines, Inc. [PRAX] is up 30.47% over the past day.

Sell
13
PSN alert for Dec 6

Parsons Corp. [PSN] is down 21.1% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock